在异性干细胞移植后进行预防性治疗的细胞巨乳病毒DNAPCR的门值
Shin-Ichiro Fujiwara1,2, Shunto Kawamura3, Shun-Ichi Kimura3
1Division of Cell Transplantation and Transfusion, Jichi Medical University Hospital, Shimotsuke, Japan.
International journal of hematology
|February 10, 2026
概括
干细胞移植后的细胞巨乳病毒 (CMV) 反激活可以使用CMV-PCR和抗原血症试验进行监测. 预防性治疗的最佳CMV-PCR值因患者的风险和莱特莫维尔的使用而异.
科学领域:
- 血液学 血液学 血液学
- 传染性疾病 传染性疾病
- 移植免疫学 移植免疫学
背景情况:
- 细胞巨乳病毒 (CMV) 反激活是异性干细胞移植 (allo-SCT) 后的一个重大并发症.
- 监测CMV病毒载量对于及时预防性治疗至关重要,以防止疾病的进展.
- 对于CMV-PCR和抗原体检测的实用性,以及最佳的CMV-PCR值,需要在现代预防策略 (如lettermovir.
研究的目的:
- 评估CMV-PCR和成年SCT接受者的抗原血样之间的相关性.
- 根据患者风险分层和莱特莫维尔的使用,确定启动预防性治疗的最佳CMV-PCR值.
- 分析与自发性CMV清除相关的因素.
主要方法:
- 对109名获得SCT补助的成年人进行前性评估.
- 同时监测CMV使用CMV-PCR和抗原血样.
- 模拟各种CMV-PCR值 (50-1000 IU/mL) 以评估预防性治疗开始.
主要成果:
- 在CMV-PCR和抗原血症值之间观察到适度的线性相关性.
- 在基于抗原血症的治疗之前,58名患者有可检测的CMV-PCR;在PCR阳性后,54人中有31人达到抗原血症值.
- 在25名患者中发生了自发的CMV清除,与使用莱特莫维尔和缺少移植对宿主疾病有关.
- 预防性治疗开始的最佳CMV-PCR值有所不同:50 IU/mL (高风险,没有莱特莫维尔),150 IU/mL (高风险,有莱特莫维尔),500-750 IU/mL (低风险).
结论:
- CMV-PCR和抗原血症分析为监测SCT后的CMV活性提供了补充信息.
- 根据莱特莫维尔的使用和患者的风险,根据预防性治疗量身定制CMV-PCR值至关重要,以平衡过度治疗和延迟治疗.
- 莱特莫维尔的使用和没有GVHD与自发的CMV清除有关,这表明它在免疫复合中发挥了作用.
相关概念视频
PCR
238.5K
Overview
238.5K
Induced Pluripotent Stem Cells
28.1K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.1K
Adult Stem Cells
33.9K
Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously...
33.9K
Embryonic Stem Cells
32.6K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.6K
Embryonic Stem Cells
5.2K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
5.2K
DNA Isolation
200.1K
DNA from cells is required for many biotechnology and research applications, such as molecular cloning. To remove and purify DNA from cells, researchers use various methods of DNA extraction. While the specifics of different protocols may vary, some general concepts underlie the process of DNA extraction.
200.1K


